Citations

Showing 10 of 108119 citations.

Validation of a Metabolite Panel for a More Accurate Estimation of Glomerular Filtration Rate Using Quantitative LC-MS/MS
Freed, Tiffany A., Inker, Lesley A. , Toal, Douglas R., Périchon, Régis, Chen, Jingsha, Goodman, Kelli D., Zhang, Qibo , Conner, Jessie K., Hauser, Deirdre M., Vroom, Kate E.T., Oyaski, Maria L, Wulff, Jacob , Eiríksdóttir, Guðný , Guðnason, Vilmundur , Ford, Lisa A. , Levey, Andrew S. , Coresh, Josef , Torres, Vicente E.

Mayo Clinic

Clinical Chemistry | January 15, 2019 | Volume: 65 | Issue: 3 | Pages: 406-418

10.1373/clinchem.2018.288092 | PMID 30647123 Get It

AbstractBACKGROUNDClinical practice guidelines recommend estimation of glomerular filtration rate (eGFR) using validated equations based on serum creatinine (eGFRcr), cystatin C (eGFRcys), or both (eGFRcr-cys). However, when compared with the measured GFR (mGFR), only eGFRcr-cys meets recommended performance standards. Our goal was to develop a more accurate eGFR method using a panel of metabolites without creatinine, cystatin C, or demographic variables.METHODSAn ultra-performance liquid chromatography–tandem mass spectrometry assay for acetylthreonine, phenylacetylglutamine, pseudouridine, and tryptophan was developed, and a 20-day, multiinstrument analytical validation was conducted. The assay was tested in 2424 participants with mGFR data from 4 independent research studies. A new GFR equation (eGFRmet) was developed in a random subset (n = 1615) and evaluated in the remaining participants (n = 809). Performance was assessed as the frequency of large errors [estimates that differed from mGFR by at least 30% (1 − P30); goal <10%].RESULTSThe assay had a mean imprecision (≤10% intraassay, ≤6.9% interassay), linearity over the quantitative range (r2 > 0.98), and analyte recovery (98.5%–113%). There was no carryover, no interferences observed, and analyte stability was established. In addition, 1 − P30 in the validation set for eGFRmet (10.0%) was more accurate than eGFRcr (13.1%) and eGFRcys (12.0%) but not eGFRcr-cys (8.7%). Combining metabolites, creatinine, cystatin C, and demographics led to the most accurate equation (7.0%). Neither equation had substantial variation among population subgroups.CONCLUSIONSThe new eGFRmet equation could serve as a confirmatory test for GFR estimation.
The role of extracellular vesicles in cancer microenvironment and metastasis: myths and challenges
Leong, Hon S. , Leong, Hon S , Lucien, Fabrice

Mayo Clinic

Biochemical Society Transactions | January 15, 2019 | Volume: 47 | Issue: 1 | Pages: 273-280

10.1042/bst20180253 | PMID 30647137 Get It

Abstract The concept of vesicles or cell debris released by cancer cells to promote metastasis is not new, but the mechanisms used to currently ascribe their impact in metastasis are of intense debate. A significant increase in reports describing the role of cancer-derived EVs in cancer metastasis has been followed by a growing amount of uncertainty behind these claims. This review will delve into the role of EVs in promoting cancer metastasis by relying on a balanced perspective that looks at challenges faced previously by extracellular vesicle biologists, current technical limitations in the field, and overlooked physiologic mechanisms that may play a confounding role. This review will also discuss how certain experimental approaches are misleading which ultimately lead to overly optimistic mechanisms that have minimally contributed to the pathophysiology of metastasis.
Stereoscopic Particle Shadow Velocimetry
Harris, Jeff , McPhail, Michael, Truong, Christine , Fontaine, Arnold A., Harris, Jeff R.

Mayo Clinic

Volume 7: Fluids Engineering | January 15, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1115/imece2018-88013 Get It

Stereoscopic particle image velocimetry (SPIV) is a variant of particle image velocimetry (PIV) that allows for the measurement of three components of velocity along a plane in a flow field. In PIV, particles in the flow field are tracked by reflecting laser light from tracer particles into two angled cameras, allowing for the velocity field to be determined. Particle shadow velocimetry (PSV) is an inherently less expensive velocity measurement method since the method images shadows cast by particles from an LED backlight instead of scattered light from a laser. Previous studies have shown that PSV is an adequate substitute for PIV for many two-dimensional, two-component velocimetry measurements. In this work, the viability of the two-dimensional, three-component stereoscopic particle shadow velocimetry (SPSV) is demonstrated by using SPSV to examine a simple jet flow. Results obtained using SPIV are also used to provide benchmark comparison for SPSV measurements. Results show that in-plane and out-of-plane velocities measured using SPSV are comparable to those measured using SPIV.
Multicenter Interrater Reliability in the Endoscopic Assessment of Velopharyngeal Function Using a Video Instruction Tool
Miller, C. L., Bly, Randall A. , Cofer, Shelagh A. , Dahl, John P. , Serres, Lianne M. de, Goudy, Steven L. , Hartzell, Larry D. , Jabbour, Noel , Kacmarysnki, Deborah, MacArthur, Carol J. , Messner, Anna H. , Milczuk, Henry A., Rastatter, Jeff C., Rosenthal, Laura H. Swibel , Scott, Andrew R. , Woolley, Audie L., Zdanski, Carlton J. , Zopf, Dave A., Sie, Kathleen C.Y. , Cofer, Shelagh, Miller, Craig, Tollefson, Travis T.

Mayo Clinic

Otolaryngology–Head and Neck Surgery | January 15, 2019 | Volume: 160 | Issue: 4 | Pages: 720-728

10.1177/0194599818822989 | PMID 30642231 Get It

ObjectiveAssess interrater agreement of endoscopic assessment of velopharyngeal (VP) function before and after viewing the video instruction tool (VIT). We hypothesized improvement in interrater agreement using the Golding‐Kushner scale (GKS) after viewing the VIT.Study DesignProspective study.SettingMulti‐institutional.MethodsSixteen fellowship‐trained pediatric otolaryngologists who treat velopharyngeal insufficiency (VPI) rated 50 video segments using the GKS before and after watching the VIT. Raters assessed gap size percentage and lateral pharyngeal wall (LPW), soft palate (SP), and posterior pharyngeal wall (PPW) movement. Intraclass correlation coefficient was estimated for these continuous measures. Raters also indicated the presence of a palatal notch, Passavant's ridge, and aberrant pulsations (categorical variables). Fleiss κ coefficient was used for categorical variables. Wilcoxon signed‐rank test was performed on the difference between the pre/post individual video ratings.ResultsReliability improved for all continuous variables after watching the instructional video. The improvement was significant for PPW (0.22‐0.30, P <. 001), SP (left: 0.63‐0.68, P <. 001 and right: 0.64‐0.68, P =. 001), and LPW (left: 0.49‐0.54, P =. 01 and right: 0.49‐0.54, P =. 09) but not significant for gap size (0.65‐0.69, P =. 36). Among categorical variables, agreement on Passavant's ridge significantly improved (0.30‐0.36, P =. 03).ConclusionExposure to a video instruction tool improves interrater agreement of endoscopic assessment of VP function. Significant improvement was observed in our primary end points, specifically posterior pharyngeal wall movement, soft palate movement, and lateral pharyngeal wall movement. There was less impact of the VIT on the interrater agreement of the categorical variables, palatal notch, Passavant's ridge, and aberrant pulsations.
Marijuana Use, Respiratory Symptoms, and Pulmonary Function
Caviedes, Iván , Labarca, Gonzalo , Silva, Claudio , Fernández-Bussy, Sebastián , Labarca, Gonzalo

Mayo Clinic

Annals of Internal Medicine | January 14, 2019 | Volume: 170 | Issue: 2 | Pages: 142

10.7326/l18-0614 | PMID 30641566 Get It

Updates in the management of intradural spinal cord tumors: a radiation oncology focus
Kotecha, Rupesh , Chang, Eric L. , Brown, Paul D. , Lo, Simon S. , Samawi, Haider , Keith, Julia , Perry, James , Sahgal, Arjun , Mehta, Minesh P. , Suh, John H. , Das, Sunit

Mayo Clinic

Neuro-Oncology | January 14, 2019 | Volume: 21 | Issue: 6 | Pages: 707-718

10.1093/neuonc/noz014 | PMID 30977511 Get It

Abstract Primary spinal cord tumors represent a hetereogeneous group of central nervous system malignancies whose management is complex given the relatively uncommon nature of the disease and variety of tumor subtypes, functional neurologic deficits from the tumor, and potential morbidities associated with definitive treatment. Advances in neuroimaging; integration of diagnostic, prognostic, and predictive molecular testing into tumor classification; and developments in neurosurgical techniques have refined the current role of radiotherapy in the multimodal management of patients with primary spinal cord tumors, and corroborated the need for prospective, multidisciplinary discussion and treatment decision making. Radiotherapeutic technological advances have dramatically improved the entire continuum from treatment planning to treatment delivery, and the development of stereotactic radiosurgery and proton radiotherapy provides new radiotherapy options for patients treated in the definitive, adjuvant, or salvage setting. The objective of this comprehensive review is to provide a contemporary overview of the management of primary intradural spinal cord tumors, with a focus on radiotherapy.
Outcomes Associated With Cardiogenic Shock in Takotsubo Syndrome
Vece, Davide Di , Citro, Rodolfo , Cammann, Victoria L. , Kato, Ken , Gili, Sebastiano , Szawan, Konrad A. , Micek, Jozef, Jurisic, Stjepan , Ding, Katharina J., Bacchi, Beatrice , Schwyzer, Moritz , Candreva, Alessandro , Bossone, Eduardo , Sarcon, Annahita, Franke, Jennifer , Napp, L. Christian , Münzel, Thomas , Knorr, Maike, Heiner, Susanne, Katus, Hugo A. , Burgdorf, Christof , Tschöpe, Carsten , Pieske, Burkert , Rajan, Lawrence, Michels, Guido, Pfister, Roman , Jacobshagen, Claudius, Hasenfuβ, Gerd, Karakas, Mahir , Köenig, Wolfgang , Rottbauer, Wolfgang , Said, Samir M., Banning, Adrian , Cuculi, Florim , Kobza, Richard , Fischer, Thomas, Vasankari, Tuija , Airaksinen, Juhani , Dworakowski, Rafał , MacCarthy, Philip , Osswald, Stefan , Galiuto, Leonarda , Dichtl, Wolfgang , Empen, Klaus , Felix, Stephan B. , Delmas, Clément , El‐Battrawy, Ibrahim , Akın, İbrahim , Borggrefe, Martin, Gilyarova, Ekaterina, Gilyarov, Mikhail , Horowitz, John D. , Kozel, Martin , Widimský, Petr , Winchester, David E. , Ukena, Christian , Prasad, Abhiram , Böhm, Michael , Lüscher, Thomas F. , Ghadri, Jelena R. , Templin, Christian , Gilyarov, Mikhail , Bossone, Eduardo , Citro, Rodolfo , El-Battrawy, Ibrahim , Prasad, Abhiram , Tschöpe, Carsten , Koenig, Wolfgang , Banning, Adrian , Kobza, Richard , Gilyarov, Mikhail , Ukena, Christian , D’Ascenzo, Fabrizio , Jaguszewski, Miłosz , Noutsias, Michel , Schunkert, Heribert , Thiele, Hölger , Bauersachs, Johann , Cuneo, Alessandro , Braun-Dullaeus, Ruediger Christian , Opolski, Grzegorz , Kaiser, Christoph A. , Crea, Filippo , Lairez, Olivier , Shilova, Alexandra S. , Toušek, Petr , Mario, Carlo Di , Bax, Jeroen J. , Ruschitzka, Frank T.

Mayo Clinic

Circulation | January 14, 2019 | Volume: 139 | Issue: 3 | Pages: 413-415

10.1161/circulationaha.118.036164 | PMID 30586690 Get It

Tranexamic acid in total joint arthroplasty: the endorsed clinical practice guides of the American Association of Hip and Knee Surgeons, American Society of Regional Anesthesia and Pain Medicine, American Academy of Orthopaedic Surgeons, Hip Society, and K
Fillingham, Yale A. , Ramkumar, Dipak B. , Jevsevar, David S. , Yates, Adolph J. , Bini, Stefano A. , Memtsoudis, Stavros G. , Sayeed, Siraj A., Sah, Alexander P. , Valle, Craig J. Della , Clarke, Henry D. , Johnson, Rebecca L. , Schemitsch, Emil H.

Mayo Clinic

Regional Anesthesia & Pain Medicine | January 14, 2019 | Volume: 44 | Issue: 1 | Pages: 7-11

10.1136/rapm-2018-000024 | PMID 30640647 Get It

Clinical and hemodynamic benefit of macitentan and riociguat upfront combination in patients with pulmonary arterial hypertension
Sulica, Roxana, Sangli, Swathi , Chakravarti, Aloke, Steiger, David , Steiger, David J.

Mayo Clinic

Pulmonary Circulation | January 14, 2019 | Volume: 9 | Issue: 1 | Pages: 1-8

10.1177/2045894019826944 | PMID 30638432 Get It

In this open‐label study, we evaluated the effect of upfront macitentan and riociguat combination in newly diagnosed pulmonary arterial hypertension (PAH) patients. In 15 consecutive PAH patients, we collected clinical and hemodynamic data at baseline, visit 1 (median 4 months) and visit 2 (median 12 months). Survival and transplantation status were analyzed over 36 months. Statistical analysis included student t‐test and 95% confidence interval (CI) (t‐statistic or Clopper‐Pearson). Kaplan‐Meier was used to estimate survival rate. There were 11/15 women (mean age 56 years), in World Health Organization (WHO) functional class (FC) III (n = 14) or IV (n = 1). The 6 min walk distance increased from 281.6 m (baseline) to 315.7 m (visit 1) and visit 2 (313.9 m), representing a 34‐ and 32‐m change (P < 0.05), respectively, associated with Borg score improvements. Brain natriuretic peptide decreased: 318.2 pg/mL (baseline) to 122.0 pg/mL (visit 1) and 98.6 pg/mL (visit 2) (P < 0.05). WHO FC improved in eight patients (53%, 95% CI 27%–79%). Pulmonary vascular resistance (9.2 to 5.7 Wood Units) and mean pulmonary artery pressure (47.3 to 38.9 mmHg) decreased; cardiac index increased (2.3 to 3.0 L/min/m2) (baseline to visit 2, all P < 0.05). All patients had intermediate and high risk score (baseline); at 1‐year follow‐up, dual therapy led to reduction to low risk score in 7/15 (47%) patients. There were no unexpected or serious side effects. Three patients died due to unrelated causes; one patient received a lung transplant. Transplant‐free survival rate (36 months) was 85%. Preliminary evidence is provided for effectiveness of initial macitentan and riociguat combination therapy in PAH.
Head CT overuse in children with a mild traumatic brain injury within two Canadian emergency departments
Gariépy, Martin , Gravel, Jocelyn , Légaré, France , Melnick, Edward R. , Lelaidier-Hould, Lania, Truchon, Catherine, Sauvé, Louise , Plante, Patrick , Sage, Natalie Le , Archambault, Patrick , Melnick, Edward R , Gariepy, Martin, Hess, Erik P. , Witteman, Holly

Mayo Clinic

Paediatrics & Child Health | January 14, 2019 | Volume: 25 | Issue: 1 | Pages: 26-32

10.1093/pch/pxy180 | PMID 33390737 Get It

Abstract Background The validated Pediatric Emergency Care Applied Network (PECARN) rule helps determine the relevance of a head computerized tomography (CT) for children with mild traumatic brain injury (mTBI). We sought to estimate the potential overuse of head CT within two Canadian emergency departments (EDs). Methods We conducted a retrospective chart review of children seen in 2016 in a paediatric Level I (site 1) and a general Level II (site 2) trauma centre. We reviewed charts to determine the appropriateness of head CT use according to the PECARN rule in a random subset of children presenting with head trauma. Simple descriptive statistics were applied. Results One thousand five hundred and forty-six eligible patients younger than 17 years consulted during the study period. Of the 203 randomly selected cases per setting, 16 (7.9%) and 24 (12%), respectively from sites 1 and 2 had a head CT performed. Based on the PECARN rule, we estimated the overuse for the younger group (&lt;2 years) to be below 3% for both hospitals without significant difference between them. For the older group (≥2 years), the overuse rate was higher at site 2 (9.3%, 95% confidence interval [CI]: 4.8 to 17% versus 1.2%, 95% CI: 0.2 to 6.5%, P=0.03). Conclusion Both EDs demonstrated overuse rates below 10% although it was higher for the older group at site 2. Such low rates can potentially be explained by the university affiliation of both hospitals and by two Canadian organizations working to raise awareness among physicians about the overuse of diagnostic tools and dangers inherent to radiation.